Cargando…
Impella use in real-world cardiogenic shock patients: Sobering outcomes
BACKGROUND: Critically ill patients with cardiogenic shock could benefit from ventricular assist device support using the Impella microaxial blood pump. However, recent studies suggested Impella not to improve outcomes. We, therefore, evaluated outcomes and predictors in a real-world scenario. METHO...
Autores principales: | Abdullah, Khaled Q. A., Roedler, Jana V., vom Dahl, Juergen, Szendey, Istvan, Haake, Hendrik, Eckardt, Lars, Topf, Albert, Ohnewein, Bernhard, Jirak, Peter, Motloch, Lukas J., Wernly, Bernhard, Larbig, Robert |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7909706/ https://www.ncbi.nlm.nih.gov/pubmed/33635889 http://dx.doi.org/10.1371/journal.pone.0247667 |
Ejemplares similares
-
Cardiac Arrhythmias in Survivors of Sudden Cardiac Death Requiring Impella Assist Device Therapy
por: Abdullah, Khaled Q. A., et al.
Publicado: (2021) -
Impact of cavotricuspid isthmus ablation for typical atrial flutter and heart failure in the elderly—results of a retrospective multi-center study
por: Boxhammer, Elke, et al.
Publicado: (2023) -
Impella versus extracorporal life support in cardiogenic shock: a propensity score adjusted analysis
por: Wernly, Bernhard, et al.
Publicado: (2021) -
Renal Protection and Hemodynamic Improvement by Impella(®) Microaxial Pump in Patients with Cardiogenic Shock
por: Patsalis, Nikolaos, et al.
Publicado: (2022) -
Impella CP use in patients with non‐ischaemic cardiogenic shock
por: Maniuc, Octavian, et al.
Publicado: (2019)